About Gossamer Bio (GOSS)
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company's product candi... Read more
- USD0.99
- USD1.00
- USD0.90
- USD1.55
- -25.10%
- 115M
- 2.46M
- 1.65M
- 191M
- 0.50
- 43.00%
Stock News
4 hours ago
Stock-market investors can’t shake tariff uncertainty. Trade deals hold the key.
MarketWatch
7 hours ago
Don’t try to be the best performer in your workplace, AT&T exec says—here’s why
CNBC
8 hours ago
The More It Underperforms, The More I Buy
SeekingAlpha
10 hours ago
Range Resources: Mr. Market Can Be Picky At Times
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
